Matches in Wikidata for { <http://www.wikidata.org/entity/Q92691462> ?p ?o ?g. }
- Q92691462 description "2020 nî lūn-bûn" @default.
- Q92691462 description "2020年の論文" @default.
- Q92691462 description "2020年学术文章" @default.
- Q92691462 description "2020年学术文章" @default.
- Q92691462 description "2020年学术文章" @default.
- Q92691462 description "2020年学术文章" @default.
- Q92691462 description "2020年学术文章" @default.
- Q92691462 description "2020年学术文章" @default.
- Q92691462 description "2020年學術文章" @default.
- Q92691462 description "2020年學術文章" @default.
- Q92691462 description "2020年學術文章" @default.
- Q92691462 description "2020年學術文章" @default.
- Q92691462 description "2020年學術文章" @default.
- Q92691462 description "2020년 논문" @default.
- Q92691462 description "article científic" @default.
- Q92691462 description "article scientific" @default.
- Q92691462 description "article scientifique" @default.
- Q92691462 description "articol științific" @default.
- Q92691462 description "articolo scientifico" @default.
- Q92691462 description "artigo científico" @default.
- Q92691462 description "artigo científico" @default.
- Q92691462 description "artigo científico" @default.
- Q92691462 description "artikel ilmiah" @default.
- Q92691462 description "artikull shkencor" @default.
- Q92691462 description "artikulong pang-agham" @default.
- Q92691462 description "artykuł naukowy" @default.
- Q92691462 description "artículo científico publicado en 2020" @default.
- Q92691462 description "artículu científicu" @default.
- Q92691462 description "bilimsel makale" @default.
- Q92691462 description "bài báo khoa học" @default.
- Q92691462 description "naučni članak" @default.
- Q92691462 description "scienca artikolo" @default.
- Q92691462 description "scientific article published on 13 January 2020" @default.
- Q92691462 description "scientific article published on 13 January 2020" @default.
- Q92691462 description "scientific article published on 13 January 2020" @default.
- Q92691462 description "teaduslik artikkel" @default.
- Q92691462 description "tieteellinen artikkeli" @default.
- Q92691462 description "tudományos cikk" @default.
- Q92691462 description "vedecký článok" @default.
- Q92691462 description "vetenskaplig artikel" @default.
- Q92691462 description "videnskabelig artikel udgivet 13. januar 2020" @default.
- Q92691462 description "vitenskapelig artikkel" @default.
- Q92691462 description "vitskapeleg artikkel" @default.
- Q92691462 description "vědecký článek" @default.
- Q92691462 description "wetenschappelijk artikel" @default.
- Q92691462 description "wissenschaftlicher Artikel" @default.
- Q92691462 description "επιστημονικό άρθρο" @default.
- Q92691462 description "мақолаи илмӣ" @default.
- Q92691462 description "наукова стаття, опублікована в січні 2020" @default.
- Q92691462 description "научна статия" @default.
- Q92691462 description "научная статья" @default.
- Q92691462 description "научни чланак" @default.
- Q92691462 description "научни чланак" @default.
- Q92691462 description "מאמר מדעי" @default.
- Q92691462 description "مقالة علمية نشرت في 13 يناير 2020" @default.
- Q92691462 description "১৩ জানুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q92691462 description "บทความทางวิทยาศาสตร์" @default.
- Q92691462 description "სამეცნიერო სტატია" @default.
- Q92691462 name "Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018" @default.
- Q92691462 name "Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018" @default.
- Q92691462 type Item @default.
- Q92691462 label "Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018" @default.
- Q92691462 label "Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018" @default.
- Q92691462 prefLabel "Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018" @default.
- Q92691462 prefLabel "Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018" @default.
- Q92691462 P1433 Q92691462-99AFD3DE-12AE-46B7-9498-EED2E0F01EB1 @default.
- Q92691462 P1476 Q92691462-F4124199-9AAB-4949-827D-24B8048F36D7 @default.
- Q92691462 P2093 Q92691462-0983AC7A-89F4-4A46-9AB6-B3BDC89290B4 @default.
- Q92691462 P2093 Q92691462-1AF758A8-6E35-4663-9D1D-1DE4E575A57F @default.
- Q92691462 P2093 Q92691462-2574BCF9-14E0-4917-A579-F0DB6490622D @default.
- Q92691462 P2093 Q92691462-40E7968D-4582-4DE9-B834-B9379F88D877 @default.
- Q92691462 P2093 Q92691462-6E02413C-B9AF-4724-9F00-900EDAB1C14A @default.
- Q92691462 P2093 Q92691462-7A5957C3-C6CC-47CE-8558-6D43EAD855ED @default.
- Q92691462 P2093 Q92691462-7E433DC3-350E-4C08-9AD0-883E4D772D51 @default.
- Q92691462 P2093 Q92691462-8D91EE44-865E-43A2-ADE1-DAF3CF896915 @default.
- Q92691462 P2093 Q92691462-A56CA981-1176-4048-9386-90AB0E59059D @default.
- Q92691462 P2093 Q92691462-AEA8414F-B0D4-4032-BCCA-7A66AA804FF0 @default.
- Q92691462 P2093 Q92691462-B70B7FF8-4FC0-4248-8AF4-50D554834929 @default.
- Q92691462 P2093 Q92691462-D47916CB-37FC-4CE4-81E4-6BBD880854B2 @default.
- Q92691462 P2093 Q92691462-D7B889DE-2E35-423E-8F4C-DC2522E860B9 @default.
- Q92691462 P2093 Q92691462-DCBEA6E9-0346-4EB6-B6A2-FAB32148C61B @default.
- Q92691462 P2093 Q92691462-E8A216BB-5B50-4E5C-858E-5019BB4C639C @default.
- Q92691462 P2093 Q92691462-FB47E3FA-447C-41E1-A2BE-5E32C14AE406 @default.
- Q92691462 P2093 Q92691462-FF59B781-0C0C-4412-B631-1B86BAE5B577 @default.
- Q92691462 P2860 Q92691462-8B5FD298-4A58-428A-BD9F-4E2A95D9360C @default.
- Q92691462 P304 Q92691462-D72D1175-9851-458A-BB77-9B65C14F1916 @default.
- Q92691462 P31 Q92691462-6DD61FF8-BA90-4A61-B493-80CC507C2124 @default.
- Q92691462 P356 Q92691462-695EFB1C-4344-4D71-A909-037A3185B6FC @default.
- Q92691462 P433 Q92691462-16F50EE0-D385-4AB1-AA77-E445DFDCE6C0 @default.
- Q92691462 P478 Q92691462-AFA60E6B-66EF-4447-B729-06D56D9047E9 @default.
- Q92691462 P50 Q92691462-E7C78A3D-40D2-4FC3-B25B-BE70414C1C18 @default.
- Q92691462 P577 Q92691462-CC828760-E8E1-4CE2-8CC3-E76B45AFB44D @default.
- Q92691462 P698 Q92691462-48F9FE11-C7A8-4226-AEA7-C52BEFA2D8B3 @default.
- Q92691462 P921 Q92691462-7E447EA8-6349-4E52-ABA8-E662A48E884B @default.
- Q92691462 P921 Q92691462-871E472C-F058-490B-AF97-7B63CCC44130 @default.
- Q92691462 P356 J.JTHO.2019.12.129 @default.
- Q92691462 P698 31945494 @default.
- Q92691462 P1433 Q2448056 @default.
- Q92691462 P1476 "Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018" @default.
- Q92691462 P2093 "Catherine Dubos-Arvis" @default.